REDWOOD CITY, Calif., Aug 05, 2022 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call and webcast on Monday, August 15, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal first quarter 2023 and provide a business update. Additional details are available on the Company’s website: https://www.biotricity.com
Conference Call and Webcast Information
| Event: | Biotricity Fiscal First Quarter 2023 Financial Results Conference Call |
| Date: | Monday, August 15, 2022 |
| Time: | 4:30 p.m. Eastern Time |
| Live Call: | 1-888-220-8451 (U.S. Toll-Free) or 1-646-828-8193 (International) |
| Participant Passcode: | 819266 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1561778&tp_key=c6d6c779d3 |
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until August 29, 2022 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 2688378.
About Biotricity Inc.
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity’s unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.
Contacts:
Investor relations:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
(212) 896-1254
Investors@biotricity.com
Media contacts
Erica Fiorini, PH.D., Russo Partners LLC
(212) 845-4253
Erica.Fiorini@russopartnersllc.com
